β-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons

被引:179
作者
Casley, CS
Land, JM
Sharpe, MA
Clark, JB
Duchen, MR
Canevari, L
机构
[1] UCL, Inst Neurol, Div Neurochem, London WC1N 3BG, England
[2] UCL, Dept Physiol, London WC1E 6BT, England
[3] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
beta-amyloid; Alzheimer's disease; mitochondria; neuron; astrocyte;
D O I
10.1006/nbdi.2002.0516
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-Amyloid deposition and compromised energy metabolism both occur in vulnerable brain regions in Alzheimer's disease. It is not known whether beta-amyloid is the cause of impairment of energy metabolism, nor whether impaired energy metabolism is specific to neurons. Our results, using primary neuronal cultures, show that 24-h incubation with Abeta(25-35) caused a generalized decrease in the specific activity of mitochondrial enzymes per milligram of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial number. Incubation with Abeta(25-35) decreased ATP concentration to 58% of control in neurons and 71 % of control in astrocytes. Levels of reduced glutathione were also lowered by Abeta(25-35) in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein). We conclude that 24-h treatment with extracellular Abeta(25-35) causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected. In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:258 / 267
页数:10
相关论文
共 38 条
  • [1] Mitochondria and cell death - Mechanistic aspects and methodological issues
    Bernardi, P
    Scorrano, L
    Colonna, R
    Petronilli, V
    Di Lisa, F
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 264 (03): : 687 - 701
  • [2] INTERACTION OF RAT-BRAIN PHOSPHOFRUCTOKINASE WITH ALZHEIMERS BETA-A4-AMYLOID
    BIGL, M
    ESCHRICH, K
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1995, 26 (01) : 69 - 75
  • [3] BOLANOS JP, 1995, J NEUROCHEM, V64, P1965
  • [4] THIAMINE-DEPENDENT ENZYME CHANGES IN TEMPORAL CORTEX OF PATIENTS WITH ALZHEIMERS-DISEASE
    BUTTERWORTH, RF
    BESNARD, AM
    [J]. METABOLIC BRAIN DISEASE, 1990, 5 (04) : 179 - 184
  • [5] β-amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria
    Canevari, L
    Clark, JB
    Bates, TE
    [J]. FEBS LETTERS, 1999, 457 (01) : 131 - 134
  • [6] Functional mitochondria are required for amyloid β-mediated neurotoxicity
    Cardoso, SM
    Santos, S
    Swerdlow, RH
    Oliveira, CR
    [J]. FASEB JOURNAL, 2001, 15 (06) : 1439 - +
  • [7] β-amyloid inhibits integrated mitochondrial respiration and key enzyme activities
    Casley, CS
    Canevari, L
    Land, JM
    Clark, JB
    Sharpe, MA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (01) : 91 - 100
  • [8] Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease
    de la Monte, SM
    Luong, T
    Neely, TR
    Robinson, D
    Wands, JR
    [J]. LABORATORY INVESTIGATION, 2000, 80 (08) : 1323 - 1335
  • [9] THE HEPATOCELLULAR METABOLISM OF 4-HYDROXYNONENAL BY ALCOHOL-DEHYDROGENASE, ALDEHYDE DEHYDROGENASE, AND GLUTATHIONE-S-TRANSFERASE
    HARTLEY, DP
    RUTH, JA
    PETERSEN, DR
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 316 (01) : 197 - 205
  • [10] Mitochondrial abnormalities in Alzheimer's disease
    Hirai, K
    Aliev, G
    Nunomura, A
    Fujioka, H
    Russell, RL
    Atwood, CS
    Johnson, AB
    Kress, Y
    Vinters, HV
    Tabaton, M
    Shimohama, S
    Cash, AD
    Siedlak, SL
    Harris, PLR
    Jones, PK
    Petersen, RB
    Perry, G
    Smith, MA
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (09) : 3017 - 3023